Benny Landa: Teva would be wrong to buy Mylan

The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.

Benny Landa

Benny Landa feels confused. The successful entrepreneur, one of the fathers of Israel’s digital printing equipment industry, does not quite understand why Israel’s Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) insists on acquiring US rival Mylan (MYL).


In late 2013, Landa became an activist investor in Teva because of his dissatisfaction with the performance of its board of directors, chiefly over the ouster of Jeremy Levin as CEO.

Since then, Phillip Frost has been replaced as chairman of Teva by former Cellcom Israel Ltd. (NYSE:CEL; TASE:CEL) CEO Yitzhak Peterburg, and Erez Vigodman, who formerly headed Makhteshim-Agan, took over as CEO fifteen months ago….



GLOBES logo-eng (1)

Published by Globes [online], Israel business news –

Read more about: , , , , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems